AZ’s Danicopan Could Protect Ultomiris After Pivotal Combination Success In PNH

 
• By Ayisha Sharma

The major’s factor D inhibitor has increased hemoglobin in a subset of paroxysmal nocturnal hemoglobinuria patients when added to a C5 inhibitor, paving the way for an approval that could help protect Ultomiris from competition.  

woman in yellow top looking tired
PNH Patients With EVH Experience Fatigue, Among Other Symptoms • Source: Shutterstock

More from Clinical Trials

More from R&D